211 related articles for article (PubMed ID: 24503588)
21. Harmonised human biomonitoring in Europe: activities towards an EU HBM framework.
Joas R; Casteleyn L; Biot P; Kolossa-Gehring M; Castano A; Angerer J; Schoeters G; Sepai O; Knudsen LE; Joas A; Horvat M; Bloemen L
Int J Hyg Environ Health; 2012 Feb; 215(2):172-5. PubMed ID: 21940209
[TBL] [Abstract][Full Text] [Related]
22. Undiagnosed Diseases: Italy-US Collaboration and International Efforts to Tackle Rare and Common Diseases Lacking a Diagnosis.
Taruscio D; Floridia G; Salvatore M; Groft SC; Gahl WA
Adv Exp Med Biol; 2017; 1031():25-38. PubMed ID: 29214564
[TBL] [Abstract][Full Text] [Related]
23. Rare Diseases in Europe: from a Wide to a Local Perspective.
Baldovino S; Moliner AM; Taruscio D; Daina E; Roccatello D
Isr Med Assoc J; 2016 Jun; 18(6):359-63. PubMed ID: 27468531
[TBL] [Abstract][Full Text] [Related]
24. [A review of the nutritional management plans in the member states of the European Union].
Lachat C; Dehenauw S; van Camp J; Matthys C; Larondelle Y; Kolsteren P
Verh K Acad Geneeskd Belg; 2006; 68(1):55-76. PubMed ID: 16610423
[TBL] [Abstract][Full Text] [Related]
25. Creating a European Union framework for actions in the field of rare diseases.
Moliner AM
Adv Exp Med Biol; 2010; 686():457-73. PubMed ID: 20824460
[TBL] [Abstract][Full Text] [Related]
26. The new EU health strategy: a step forward or another example of 'bureaucracy total control'?
Merkel B
Clin Med (Lond); 2008 Jun; 8(3):280-2. PubMed ID: 18624035
[TBL] [Abstract][Full Text] [Related]
27. Key outcomes from stakeholder workshops at a symposium to inform the development of an Australian national plan for rare diseases.
Molster C; Youngs L; Hammond E; Dawkins H; ;
Orphanet J Rare Dis; 2012 Aug; 7():50. PubMed ID: 22883422
[TBL] [Abstract][Full Text] [Related]
28. RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.
Talarico R; Cannizzo S; Lorenzoni V; Marinello D; Palla I; Pirri S; Ticciati S; Trieste L; Triulzi I; Terol E; Bucher A; Turchetti G
Orphanet J Rare Dis; 2020 Dec; 15(1):347. PubMed ID: 33317578
[TBL] [Abstract][Full Text] [Related]
29. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
30. National support to public health research: a survey of European ministries.
Conceição C; Leandro A; McCarthy M
BMC Public Health; 2009 Jun; 9():203. PubMed ID: 19555492
[TBL] [Abstract][Full Text] [Related]
31. Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey.
Bjarnason-Wehrens B; McGee H; Zwisler AD; Piepoli MF; Benzer W; Schmid JP; Dendale P; Pogosova NG; Zdrenghea D; Niebauer J; Mendes M;
Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):410-8. PubMed ID: 20300001
[TBL] [Abstract][Full Text] [Related]
32. A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries.
Czech M; Baran-Kooiker A; Atikeler K; Demirtshyan M; Gaitova K; Holownia-Voloskova M; Turcu-Stiolica A; Kooiker C; Piniazhko O; Konstandyan N; Zalis'ka O; Sykut-Cegielska J
Front Public Health; 2019; 7():416. PubMed ID: 32117845
[No Abstract] [Full Text] [Related]
33. Primary prevention of congenital anomalies: recommendable, feasible and achievable.
Taruscio D; Mantovani A; Carbone P; Barisic I; Bianchi F; Garne E; Nelen V; Neville AJ; Wellesley D; Dolk H
Public Health Genomics; 2015; 18(3):184-91. PubMed ID: 25791968
[TBL] [Abstract][Full Text] [Related]
34. The Directorate-General for Health and Consumers 1999-2014: An assessment of its functional capacities.
Clemens T; Sørensen K; Rosenkötter N; Michelsen K; Brand H
Health Policy; 2017 Jun; 121(6):594-603. PubMed ID: 28446384
[TBL] [Abstract][Full Text] [Related]
35. Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network.
Salvatore M; Polizzi A; De Stefano MC; Floridia G; Baldovino S; Roccatello D; Sciascia S; Menegatti E; Remuzzi G; Daina E; Iatropoulos P; Bembi B; Da Riol RM; Ferlini A; Neri M; Novelli G; Sangiuolo F; Brancati F; Taruscio D
Ital J Pediatr; 2020 Sep; 46(1):130. PubMed ID: 32928283
[TBL] [Abstract][Full Text] [Related]
36. Comparison of legislation, regulations and national health strategies for palliative care in seven European countries (Results from the Europall Research Group): a descriptive study.
Van Beek K; Woitha K; Ahmed N; Menten J; Jaspers B; Engels Y; Ahmedzai SH; Vissers K; Hasselaar J
BMC Health Serv Res; 2013 Jul; 13():275. PubMed ID: 23866928
[TBL] [Abstract][Full Text] [Related]
37. Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states.
Kinsman J; Angrén J; Elgh F; Furberg M; Mosquera PA; Otero-García L; Snacken R; Derrough T; Carrillo Santisteve P; Ciotti M; Tsolova S
BMC Health Serv Res; 2018 Jul; 18(1):528. PubMed ID: 29976185
[TBL] [Abstract][Full Text] [Related]
38. The role of the European Union in health policies of member states - an example of the rare diseases policy in Croatia.
Ivčić S; Radin D
Croat Med J; 2021 Dec; 62(6):553-560. PubMed ID: 34981687
[TBL] [Abstract][Full Text] [Related]
39. European network for health technology assessment, EUnetHTA: planning, development, and implementation of a sustainable European network for health technology assessment.
Kristensen FB; Mäkelä M; Neikter SA; Rehnqvist N; Håheim LL; Mørland B; Milne R; Nielsen CP; Busse R; Lee-Robin SH; Wild C; Espallargues M; Chamova J;
Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():107-16. PubMed ID: 20030898
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
